GLP-1s can be expensive, but many insurance plans now cover them for patients who qualify
While brief exposures are not catastrophic, cumulative light exposure over weeks adds up
Yes, non-diabetic patients can lose weight on Rybelsus, but it is FDA-approved only for type 2 diabetes
However, as the GLP-1 albumin fusion and unfused albumin have the same theoretical pI, and only small differences in pH-dependent net charge, this probably does not explain the discrepancy between their FcRn binding properties and cellular handling or plasma half-life
Some insurance plans may cover these medications if prescribed for qualifying health conditions
*In a 72-week study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5mg, 19.5% (44 lbs) for 10mg, 20.9% (48 lbs) for 15 mg, and 3.1 (7 lbs) for placebo